U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07582185) titled 'Tdose Binding and Tocilizumab' on May 06.
Brief Summary: The investigators aim to evaluate the non-inferiority of administering tocilizumab at a fixed dose versus a weight-based dose in patients with rheumatoid arthritis in remission or with low clinical activity, after 3 months of treatment, as part of a two-center randomized trial.
Study Start Date: June 01
Study Type: INTERVENTIONAL
Condition:
Rheumatoid Arthritis
Intervention:
DRUG: Experimental: dose binding arm
TOCILIZUMAB administered at standardized, fixed-interval doses versus weight-based dosing
DRUG: Active Comparator: traditionnal arm: Weight-based dosing
standar...